drugset / Trial / NCT03814109

Efficacy and Safety of Leningrado Association in the Treatment of Hypertension

NCT03814109

Phase 3 Withdrawn EMS
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy and safety of Leningrado association on the treatment of hypertension.

Timeline

Start
2022-04
Primary completion
2023-11
Completion
2024-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Indapamide SR 1.5 MG Unknown 1.5 mg Oral
Subject LENINGRADO association Unknown Oral
Comparator S-amlodipine Unknown 2.5 mg Oral
Comparator S-amlodipine Unknown 5 mg Oral

Indications